House concurrent resolution designating April 6, 2023 as Alzheimer’s Awareness Day at the State House
The resolution emphasizes the considerable financial burden that Alzheimer's disease places on Medicaid and the broader healthcare system. In 2020, Vermont's Medicaid costs for Alzheimer's care reached $116 million, with anticipations of a 26.4 percent increase by 2025. This resolution aims to inform legislators and encourage them to consider the implications of Alzheimer's on healthcare policies, especially as hospitalization and care costs continue to rise, potentially reaching a national financial burden of $1 trillion by 2050.
HCR076 is a House concurrent resolution that designates April 6, 2023, as Alzheimer's Awareness Day at the State House in Vermont. The resolution acknowledges Alzheimer's disease as a significant degenerative brain condition, highlighting the increasing prevalence of the disease, with predictions indicating that the number of Vermonters diagnosed will surge by over 30 percent in the coming years. The resolution serves not only to raise awareness but also to bring attention to the challenges faced by caregivers and the economic impact of this disease on the healthcare system in the state.
The sentiment surrounding HCR076 is largely supportive, reflecting a recognition of the impact Alzheimer's has on individuals, families, and the healthcare system. Advocates for Alzheimer's awareness express gratitude for the legislature's acknowledgement of the issue, viewing the designated day as an important opportunity to highlight the need for research, support services, and caregiver assistance. The discussions surrounding the resolution indicate a unified front among legislators regarding the importance of addressing the challenges posed by this disease.
While HCR076 is primarily a resolution for awareness, the underlying issues related to Alzheimer’s disease generate significant discourse about healthcare funding and support for caregivers in Vermont. The resolution seeks to facilitate dialogue on these issues as advocates are invited to the State House to share concerns. Although this resolution is generally supported, the increasing prevalence of the disease and the projected costs may lead to future debates about resource allocation and prioritization within state healthcare initiatives.